Open AccessIdentification of novel markers for liver fibrosis in HIV/hepatitis C virus coinfected individuals using genomics-based approach
Author(s) -
Daniel L. Suzman,
Mary McLaughlin,
Zonghui Hu,
David E. Kleiner,
Bradford J. Wood,
Richard A. Lempicki,
JoAnn M. Mican,
Anthony F. Suffredini,
Henry Masur,
Michael A. Polis,
Shyam Kottilil
Publication year - 2008
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e328304dfe7
Subject(s) - hepatitis c virus , virology , hepatitis c , genomics , identification (biology) , liver fibrosis , hepacivirus , human immunodeficiency virus (hiv) , medicine , biology , fibrosis , virus , computational biology , genome , immunology , genetics , pathology , gene , botany
The degree of liver fibrosis is a determinant for initiation of therapy for hepatitis C virus. Liver biopsy is invasive, risky and costly, but is required to assess fibrosis. This study intended to identify novel noninvasive markers to accurately assess fibrosis in HIV/hepatitis C virus coinfection.